Walleye Trading
EPZM

Walleye Trading’s Epizyme, Inc EPZM Stock Holding History

Walleye Trading’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-14,400
Closed -$89K – 4963
2018
Q4 		$89K Buy
14,400
+13,400
+1,340% +$102K ﹤0.01% 3944
2018
Q3 		$11K Buy
+1,000
New +$11.4K ﹤0.01% 4977
2018
Q2 		– Sell
-10,471
Closed -$186K – 5035
2018
Q1 		$186K Buy
+10,471
New +$177K ﹤0.01% 3547

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Walleye Trading's EPZM Position: Q1 2019 in Review

Walleye Trading sold out of Epizyme, Inc (EPZM) in Q1 2019, closing a stake of 14,400 shares — an estimated $89K sold.

Walleye Trading first reported a position in EPZM in Q1 2018 and held it in 3 quarters. The position peaked at $186K in Q1 2018. 121 funds tracked by Wall St. Rank hold EPZM as of Q1 2019.

  • Walleye Trading reported no remaining Epizyme, Inc position as of Q1 2019 after selling out during the quarter.
  • Walleye Trading sold 14,400 Epizyme, Inc shares in Q1 2019, an estimated $89K.
  • Walleye Trading first reported a position in Epizyme, Inc in Q1 2018 and held it in 3 quarters.
  • Walleye Trading's Epizyme, Inc position peaked at $186K in Q1 2018.
  • 121 funds tracked by Wall St. Rank held Epizyme, Inc as of Q1 2019.

Based on Walleye Trading's 13F filing for Q1 2019, filed 15 May 2019.